The stock of Exova Group Plc (LON:EXO) is a huge mover today! The stock closed at GBX 190 during the last session. It is up 18.75% since April 29, 2016 and is uptrending. It has outperformed by 12.74% the S&P500.
The move comes after 6 months negative chart setup for the GBX 486.05M company. It was reported on Nov, 28 by Barchart.com. We have GBX 174.80 PT which if reached, will make LON:EXO worth GBX 38.88 million less.
Exova Group Plc (LON:EXO) Ratings Coverage
Out of 6 analysts covering Exova Group Plc (LON:EXO), 6 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Exova Group Plc has been the topic of 27 analyst reports since August 24, 2015 according to StockzIntelligence Inc. As per Friday, November 25, the company rating was maintained by Barclays Capital. The rating was maintained by Credit Suisse with “Outperform” on Wednesday, November 11. Barclays Capital maintained the shares of EXO in a report on Thursday, September 1 with “Overweight” rating. The stock of Exova Group Plc (LON:EXO) has “Buy” rating given on Wednesday, November 11 by Investec. The rating was maintained by Goldman Sachs on Friday, November 25 with “Buy”. Shore Capital maintained the shares of EXO in a report on Thursday, September 22 with “Buy” rating. Investec maintained Exova Group Plc (LON:EXO) on Friday, August 28 with “Buy” rating. As per Monday, July 4, the company rating was maintained by Shore Capital. The firm earned “Buy” rating on Tuesday, February 23 by Shore Capital. The stock of Exova Group Plc (LON:EXO) earned “Buy” rating by Goldman Sachs on Thursday, September 1.
Exova Group plc is a United Kingdom well-known provider of testing and advisory services. The company has a market cap of 486.05 million GBP. The Firm is a laboratory testing firm operating approximately 140 laboratories and offices in over 30 countries throughout Europe, the Americas, the Middle East and Asia/Asia Pacific. It has a 23.28 P/E ratio. The Company’s divisions include Europe, Americas and Rest of World.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.